These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. The psychological consequences of tardive dyskinesia. The effect of drug-induced parkinsonism and the topography of the dyskinetic movements. Brown KW; White T Br J Psychiatry; 1991 Sep; 159():399-403. PubMed ID: 1683594 [TBL] [Abstract][Full Text] [Related]
12. Short-term effect of combined ECT and neuroleptic therapy in treatment-resistant schizophrenia. Chanpattana W; Chakrabhand ML; Kongsakon R; Techakasem P; Buppanharun W J ECT; 1999 Jun; 15(2):129-39. PubMed ID: 10378152 [TBL] [Abstract][Full Text] [Related]
13. Differentiating primary from secondary negative symptoms in schizophrenia: a study of neuroleptic-naive patients before and after treatment. Peralta V; Cuesta MJ; Martinez-Larrea A; Serrano JF Am J Psychiatry; 2000 Sep; 157(9):1461-6. PubMed ID: 10964863 [TBL] [Abstract][Full Text] [Related]
14. Neuroleptic dose and schizophrenic symptoms. A survey of prescribing practices. Peralta V; Cuesta MJ; Caro F; Martinez-Larrea A Acta Psychiatr Scand; 1994 Nov; 90(5):354-7. PubMed ID: 7872040 [TBL] [Abstract][Full Text] [Related]
15. Usefulness of antiparkinsonian drugs during neuroleptic treatment and the effect of clonazepam on akathisia and parkinsonism occurred after antiparkinsonian drug withdrawal: a double-blind study. Horiguchi J; Nishimatsu O Jpn J Psychiatry Neurol; 1992 Sep; 46(3):733-9. PubMed ID: 1362592 [TBL] [Abstract][Full Text] [Related]
16. The influence of concomitant neuroleptic medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy. Nothdurfter C; Eser D; Schüle C; Zwanzger P; Marcuse A; Noack I; Möller HJ; Rupprecht R; Baghai TC World J Biol Psychiatry; 2006; 7(3):162-70. PubMed ID: 16861142 [TBL] [Abstract][Full Text] [Related]
17. Drug-induced parkinsonism: relationship to age at onset of schizophrenia. Sandyk R; Kay SR Funct Neurol; 1991; 6(2):151-7. PubMed ID: 1680777 [TBL] [Abstract][Full Text] [Related]
18. Relationship between negative symptoms in chronic schizophrenia and neuroleptic dose, plasma levels and side effects. Tugg LA; Desai D; Prendergast P; Remington G; Reed K; Zipursky RB Schizophr Res; 1997 May; 25(1):71-8. PubMed ID: 9176929 [TBL] [Abstract][Full Text] [Related]
19. Continuation electroconvulsive therapy for relapse prevention in middle-aged and elderly patients with intractable catatonic schizophrenia. Suzuki K; Awata S; Takano T; Ebina Y; Iwasaki H; Matsuoka H Psychiatry Clin Neurosci; 2005 Aug; 59(4):481-9. PubMed ID: 16048455 [TBL] [Abstract][Full Text] [Related]
20. Effectiveness of Electroconvulsive Therapy and Associated Cognitive Change in Schizophrenia: A Naturalistic, Comparative Study of Treating Schizophrenia With Electroconvulsive Therapy. Tor PC; Ying J; Ho NF; Wang M; Martin D; Ang CP; Tan C; Yap LS; Lu VJM; Simpson B; Mok YM; Loo C J ECT; 2017 Dec; 33(4):272-277. PubMed ID: 28640170 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]